Pneumococcal disease and the role of conjugate vaccines

被引:28
|
作者
Klein, DL [1 ]
机构
[1] NIAID, Resp Dis Branch, DMID, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1089/mdr.1999.5.147
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:147 / 157
页数:11
相关论文
共 50 条
  • [11] Meeting the challenge:: Prevention of pneumococcal disease with conjugate vaccines
    Echániz-Avilés, IG
    Solórzano-Santos, F
    SALUD PUBLICA DE MEXICO, 2001, 43 (04): : 352 - 367
  • [12] Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines
    Tan, Tina Q.
    CLINICAL MICROBIOLOGY REVIEWS, 2012, 25 (03) : 409 - 419
  • [13] The pneumococcal protein conjugate vaccines
    Peters, TR
    Edwards, KM
    JOURNAL OF PEDIATRICS, 2000, 137 (03): : 416 - 420
  • [14] Conjugate pneumococcal vaccines: an overview
    Mulholland, EK
    MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 : S48 - S50
  • [15] Impact of conjugate pneumococcal vaccines
    Whitney, CG
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (08) : 729 - 730
  • [16] Immunogenicity of pneumococcal conjugate vaccines
    Eskola, J
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (04) : 388 - 393
  • [17] NEW CONJUGATE VACCINES FOR THE PREVENTION OF PNEUMOCOCCAL DISEASE IN DEVELOPING COUNTRIES
    Ginsburg, A. S.
    Alderson, M. P.
    DRUGS OF TODAY, 2011, 47 (03) : 207 - 214
  • [18] Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada
    De Wals, Philippe
    Deceuninck, Genevieve
    De Serres, Gaston
    VACCINE, 2016, 34 (18) : 2053 - 2054
  • [19] Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012
    Lepoutre, A.
    Varon, E.
    Georges, S.
    Dorleans, F.
    Janoir, C.
    Gutmann, L.
    Levy-Bruh, D.
    VACCINE, 2015, 33 (02) : 359 - 366
  • [20] Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan
    Nakamura, Shigeki
    Mikami, Masashi
    Hayamizu, Tomoyuki
    Yonemoto, Naohiro
    Moyon, Camille
    Gouldson, Mark
    Crossan, Catriona
    Vietri, Jeffrey
    Kamei, Kazumasa
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 546 - 560